Bioanalytical Devices Research Articles

Enhanced Electron Transfer Efficiency of Fructose Dehydrogenase onto Roll-to-Roll Thermal Stamped Laser-Patterned Reduced Graphene Oxide Films.

Herein, a strategy to stamp laser-produced reduced graphene oxide (rGO) onto flexible polymers using only office-grade tools, namely, roll-to-roll thermal stamping, is proposed, proving for the first time its effectiveness for direct bioelectrocatalysis. This straightforward, scalable, and low-cost approach allows us to overcome the limits of the integration of laser-induced rGO-films in bioanalytical devices. Laser-produced rGO has been thermally stamped (TS) onto different polymeric substrates (PET, PVC, and EVA) using a simple roll-laminator; the obtained TS-rGO films have been compared with the native rGO (untransferred) via morphochemical and electrochemical characterization. Particularly, the direct electron transfer (DET) reaction between fructose dehydrogenase (FDH) and TS-rGO transducers has been investigated, with respect to the influence of the amount of enzyme on the catalytic process. Remarkable differences have been observed among TS-rGO transducers; PET proved to be the elective substrate to support the transfer of the laser-induced rGO, allowing the preservation of the morphochemical features of the native material and returning a reduced capacitive current. Noteworthily, TS-rGOs ensure superior electrocatalysis using a very low amount of FDH units (15 mU). Eventually, TS-rGO-based third-generation complete enzymatic biosensors were fabricated via low-cost benchtop technologies. TS-rGOPET exhibited bioanalytical performances superior to the native rGO, allowing a sensitive (0.0289 μA cm-2 μM-1) and reproducible (RSD = 3%, n = 3) d-fructose determination at the nanomolar level (LOD = 0.2 μM). TS-rGO exploitability as a point-of-need device was proved via the monitoring of d-fructose during banana (Musa acuminata) postharvest ripening, returning accurate (recoveries 110-90%; relative error -13/+1%) and reproducible (RSD ≤ 7%; n = 3) data.

Recent Trends of Bioanalytical Sensors with Smart Health Monitoring Systems: From Materials to Applications.

Smart biosensors attract significant interest due to real-time monitoring of user health status, where bioanalytical electronic devices designed to detect various activities and biomarkers in the human body have potential applications in physical sign monitoring and health care. Bioelectronics can be well integrated by output signals with wireless communication modules for transferring data to portable devices used as smart biosensors in performing real-time diagnosis and analysis. In this review, the scientific keys of biosensing devices and the current trends in the field of smart biosensors, (functional materials, technological approaches, sensing mechanisms, main roles, potential applications and challenges in health monitoring)will be summarized. Recent advances in the design and manufacturing of bioanalytical sensors with smarter capabilities and enhanced reliability indicate a forthcoming expansion of these smart devices from laboratory to clinical analysis. Therefore, a general description of functional materials and technological approaches used in bioelectronics will be presented after the sections of scientific keys to bioanalytical sensors. A careful introduction to the established systems of smart monitoring and prediction analysis using bioelectronics, regarding the integration of machine-learning-based basic algorithms, will be discussed. Afterward, applications and challenges in development using these smart bioelectronics in biological, clinical, and medical diagnostics will also be analyzed. Finally, the review will conclude with outlooks of smart biosensing devices assisted by machine learning algorithms, wireless communications, or smartphone-based systems on current trends and challenges for future works in wearable health monitoring.

Green synthesis of silver nanoparticles and designing a new amperometric biosensor to determine glucose levels

The high-level of glucose in daily nutrition causes diabetes (Diabetes mellitus) and obesity. It is also important to determine glucose levels in food production processes for quality control methods. Biosensors are bio analytical devices that provides cheap, simple, analyses and have a fast response time. Silver nanoparticles are used to modify electrodes in bio-sensing glucose. The nanoparticles could be synthesized via the green synthesis technique. In this technique, plants could be used both reducing and stabilizing agents. Agricultural waste, an environmental problem, is increasing with the population. These wastes are a good natural source and have the potential for green synthesis of silver nanoparticles to use in biosensor applications. In this study, a new amperometric glucose biosensor was designed. For this purpose, carbon paste electrode (CPE) was modified by green synthesized waste tea based silver nanoparticles (WT-AgNPs) and the glucose oxidase enzyme was immobilized on MCPE by the cross-linking. Glucose determination was performed based on the reduction of hydrogen peroxide at +0.4 V versus Ag/AgCl. The linear working range was determined as 0.10–1.0 µM. In addition, the designed biosensor was applied to detect the amount of glucose in a commercial fruit juice. The results showed that the designed biosensor has low detection limit, very good reproducibility, selectivity, and almost long shelf life.

Multiplex electrochemical sensing platforms for the detection of breast cancer biomarkers.

Herein, advancements in electroanalytical devices for the simultaneous detection of diverse breast cancer (BC) markers are demonstrated. This article identifies several important areas of exploration for electrochemical diagnostics and highlights important factors that are pivotal for the successful deployment of novel bioanalytical devices. We have highlighted that the limits of detection (LOD) reported for the multiplex electrochemical biosensor can surpass the sensitivity displayed by current clinical standards such as ELISA, FISH, and PCR. HER-2; a breast cancer marker characterised by increased metastatic potential, more aggressive development, and poor clinical outcomes; can be sensed with a LOD of 0.5 ng/ml using electrochemical multiplex platforms, which falls within the range of that measured by ELISA (from picogram/ml to nanogram/ml). Electrochemical multiplex biosensors are reported with detection limits of 0.53 ng/ml and 0.21 U/ml for MUC-1 and CA 15-3, respectively, or 5.8 × 10-3 U/ml for CA 15-3 alone. The sensitivity of electrochemical assays is improved when compared to conventional analysis of MUC-1 protein which is detected at 11-12 ng/ml, and ≤30 U/ml for CA 15-3 in the current clinical blood tests. The LOD for micro-ribonucleic acid (miRNA) biomarkers analyzed by electrochemical multiplex assays were all notedly superior at 9.79 × 10-16 M, 3.58 × 10-15 M, and 2.54 × 10-16 M for miRNA-155, miRNA-21, and miRNA-16, respectively. The dogma in miRNA testing is the qRT-PCR method, which reports ranges in the ng/ml level for the same miRNAs. Breast cancer exosomes, which are being explored as a new frontier of biosensing, have been detected electrochemically with an LOD of 103-108 particles/mL and can exceed detection limits seen by the tracking and analysis of nanoparticles (∼ 107 particles/ml), flow cytometry, Western blotting and ELISA, etc. A range of concentration at 78-5,000 pg/ml for RANKL and 16-1,000 pg/ml for TNF is reported for ELISA assay while LOD values of 2.6 and 3.0 pg/ml for RANKL and TNF, respectively, are demonstrated by the electrochemical dual immunoassay platform. Finally, EGFR and VEGF markers can be quantified at much lower concentrations (0.01 and 0.005 pg/ml for EGFR and VEGF, respectively) as compared to their ELISA assays (EGRF at 0.31-20 ng/ml and VEGF at 31.3-2,000 pg/ml). In this study we hope to answer several questions: (1) Are the limits of detection (LODs) reported for multiplex electrochemical biosensors of clinical relevance and how do they compare to well-established methods like ELISA, FISH, or PCR? (2) Can a single sensor electrode be used for the detection of multiple markers from one blood drop? (3) What mechanism of electrochemical biosensing is the most promising, and what technological advancements are needed to utilize these devices for multiplex POC detection? (4) Can nanotechnology advance the sensitive and selective diagnostics of multiple BC biomarkers? (5) Are there preferred receptors (antibody, nucleic acid or their combinations) and preferred biosensor designs (complementary methods, sandwich-type protocols, antibody/aptamer concept, label-free protocol)? (6) Why are we still without FDA-approved electrochemical multiplex devices for BC screening?

Advances in the noninvasive and minimally invasive sample collection for wearable electrochemical sensors

AbstractWearable electrochemical sensors, which can track various biomarkers in real‐time, is one of the most promising bioanalytical devices in the point of care testing and health management. Sample collection modules, as the important front‐end of the sensors, capture and transfer enough sample so as to achieve real‐time, precise and accurate detection. Noninvasive and minimally invasive techniques for sample collection are highly desired. However, it is still a key challenge to realize a reliable sample acquisition. Herein, we provide an overview on the progress in the sample collection methods for wearable electrochemical sensors. It covers the conventional and emerging methods/structures including reverse iontophoresis, microneedles, as well as microfluidic chips. The working principle, fabrication materials and manufacturing technologies will be introduced in detail. Finally, the present challenges and the development trend in the future of these approaches are also put forward.

Insights into diphenylalanine peptide self-assembled nanostructures for integration as nanoplatforms in analytical and medical devices

New insights on the self-assembling process of diphenylalanine (FF) into nanostructures in view of its application as an alternative nanomaterial for bioanalytical and biomedical systems are presented in the frame of the present work. Experimental conditions, such as peptide concentration and solubilization medium pH, were explored to understand the hierarchical process involved in the formation of self-assembled nanostructures arising from the simple and short diphenylalanine peptide. Optical microscopy and TEM images supported by DLS data authenticated the hierarchical self-assembly outcoming from the original nature of the first nanostructures, showing individual nanotubes and vesicles stacking to grow well-defined microtubes. Moreover, the influence of metal cations on peptide self-assembly was evaluated for the first time in the presence of Mg2+ and compared with other ions, such as Na+, K+, and Ca2+. The results evidenced a tendency of Mg2+ to interact with diphenylalanine peptides to form self-assembled nanostructures showing vesicle- and ellipse-like morphologies. FF solubilization in water prepared under sonication in a bath at 65–68 °C followed by dilution into chloride metal cation solutions at 50 mmol·L−1 proved to be optimal conditions to obtain metal-coordinated self-assembled FF structures. Besides, the latter revealed fluorescence features and electron-transfer properties on carbon-based electrode surfaces, that can be further explored in analytical and bioanalytical devices for fully integrated platforms. In this context, self-assembled nanostructures achieved in the presence of Mg2+ and Ca2+ were implemented for the surface modification of carbon screen-printed electrodes and proved to increase the electrochemical response toward a redox probe. This proof of concept is particularly interesting for further use of these peptide-based nanoarchitectures as nanoplatforms for clinical imaging, therapeutic and diagnosis purposes.

Electrochemical Protein-based Bioanalytical Devices for Drug Analysis.

Proteins are vital components of living cells and the loss of their native functions has been associated with a wide variety of medical conditions. From this point of view, investigation of the protein microenvironment is crucial to support the development of therapeutic approaches capable of ensuring cellular functions. Therefore, analytical assays for the detection, quantification, and characterization of proteins, drugs, and protein-drug complexes play an essential role in fundamental research and clinical applications. Electrochemistry arises as an alternative methodology for fast assessment of proteins and drugs and is attractive due to the adaptability to miniaturization and scalability of electroanalytical devices, which then can be further employed as strategies towards personalized medical care. Thus, this review summarizes electrochemical investigations in the past 10 years on protein-based analytical devices and biosensors. A general overview of electrochemical assays that integrate proteins with nanostructured materials and conductive polymers is presented. Applications of electrochemical assays and biosensors were divided into four categories. First, those designed for drug screening strategies that focus on targeting specific intracellular, extracellular, or membrane protein subdomains to modulate their functions, aggregation/misfolding of proteins, and protein degradation pathways. Then, drug metabolism assays that involve mimicking natural metabolic pathways to identify potential safety and efficacy issues related to a drug or its metabolites. The third was dedicated to electrochemical drug delivery systems with anchored drugs in the form of bioconjugates, while the fourth was dedicated to electroanalytical methodologies for quantitative drug assays, where the electroactivity of the target species is often used to correlate the electrochemical signal to their concentration.

Design of Cyber Bio-analytical Physical Systems: Formal methods, architectures, and multi-system interaction strategies

Integration of the Cyber–Physical System (CPS) concept with bio-analytical devices is highly desirable to enable device automation as well as to improve diagnostic and analytical capabilities. However, the modeling must account for entity interactions, system dynamics, and non-functional aspects required for proper device functionality.This paper presents a model-based system architecture that builds upon an extended timed automata-based formal technique. In contrast to prior works that utilized SysML or UML-based models, this allows for the wireless control of bio-analytical instruments. Using this formal method, the UPPAAL tool is used to model and test a case study called “A droplet flow cytometer for testing bacteria’s susceptibility to antibiotics”. The study shows the implications of formal techniques for the design and verification of wireless automation of high-throughput laboratory setups in Model-Based System Engineering (MBSE). Moreover, the paper extends the above aspects by adding the possibility to model multi-system interaction. This is used to analyze the trade-off between centralized and decentralized information flow strategies for better system performance under delay and bandwidth constraints. UPPAAL Stratego is used to analyze strategies for achieving specific delays and bandwidth consumption while avoiding packet losses in the event of network congestion. The results show that under strict delay constraints and high traffic, the use-case system selects the decentralized strategy over the centralized strategy. In low-traffic scenarios, the centralized strategy is more effective at ensuring the reliable operation of systems.

Capillary-driven microfluidics: impacts of 3D manufacturing on bioanalytical devices.

Over decades, decentralized diagnostics continues to move towards rapid and cost-effective testing at the point-of-care (POC). Although microfluidics has become a key enabling technology for POC testing, the need for robust peripheral equipment has been a key limiting factor in reaching an ideal device. Manufacturing technologies are now reaching a level of maturity that allows the definition of 3D features down to the sub-millimeter scale. Employing three-dimensional (3D) features and surface chemistry allows the possibility to pre-program sophisticated control of the capillary flow avoiding bulky peripheral equipment. By designing a sequence of steps, like elution of reagents, washing, mixing, and sensing, capillary valves have become a powerful tool for POC applications. These valves use capillary force to stop and then release flows within pre-programmed capillary circuits without any moving part. Without their 3D structure, the feasibility of creating pre-programmed bioanalytical devices would be nearly impossible. Besides, the advent of smart materials and their variety of surface properties permitted the unprecedented ability to fabricate reliable flow control with a range of capillary driving forces. The classification of such capillary elements is presented in two functional steps - stop and actuation. This review includes the advances in 3D microfabrication, design, and surface chemistry for manufacturing bioanalytical devices. These developments are critically reviewed, focusing on the process and considering phenomena such as timing, reproducibility, unwanted diffusion, and cross-contaminations.

Emerging Bioanalytical Devices and Platforms for Rapid Detection of Pathogens in Environmental Samples.

The development of robust bioanalytical devices and biosensors for infectious pathogens is progressing well with the advent of new materials, concepts, and technology. The progress is also stepping towards developing high throughput screening technologies that can quickly identify, differentiate, and determine the concentration of harmful pathogens, facilitating the decision-making process for their elimination and therapeutic interventions in large-scale operations. Recently, much effort has been focused on upgrading these analytical devices to an intelligent technological platform by integrating them with modern communication systems, such as the internet of things (IoT) and machine learning (ML), to expand their application horizon. This review outlines the recent development and applications of bioanalytical devices and biosensors to detect pathogenic microbes in environmental samples. First, the nature of the recent outbreaks of pathogenic microbes such as foodborne, waterborne, and airborne pathogens and microbial toxins are discussed to understand the severity of the problems. Next, the discussion focuses on the detection systems chronologically, starting with the conventional methods, advanced techniques, and emerging technologies, such as biosensors and other portable devices and detection platforms for pathogens. Finally, the progress on multiplex assays, wearable devices, and integration of smartphone technologies to facilitate pathogen detection systems for wider applications are highlighted.

Innovations and Challenges in Electroanalytical Tools for Rapid Biosurveillance of SARS-CoV-2.

Since the onset of the coronavirus disease 2019 (COVID‐19) pandemic, preventive social paradigms and vaccine development have undergone serious renovations, which drastically reduced the viral spread and increased collective immunity. Although the technological advancements in diagnostic systems for severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) detection are groundbreaking, the lack of sensitive, robust, and consumer‐end point‐of‐care (POC) devices with smartphone connectivity are conspicuously felt. Despite its revolutionary impact on biotechnology and molecular diagnostics, the reverse transcription polymerase chain reaction technique as the gold standard in COVID‐19 diagnosis is not suitable for rapid testing. Today's POC tests are dominated by the lateral flow assay technique, with inadequate sensitivity and lack of internet connectivity. Herein, the biosensing advancements in Internet of Things (IoT)‐integrated electroanalytical tools as superior POC devices for SARS‐CoV‐2 detection will be demonstrated. Meanwhile, the impeding factors pivotal for the successful deployment of such novel bioanalytical devices, including the incongruous standards, redundant guidelines, and the limitations of IoT modules will be discussed.

Pore performance: artificial nanoscale constructs that mimic the biomolecular transport of the nuclear pore complex.

The nuclear pore complex is a nanoscale assembly that achieves shuttle-cargo transport of biomolecules: a certain cargo molecule can only pass the barrier if it is attached to a shuttle molecule. In this review we summarize the most important efforts aiming to reproduce this feature in artificial settings. This can be achieved by solid state nanopores that have been functionalized with the most important proteins found in the biological system. Alternatively, the nanopores are chemically modified with synthetic polymers. However, only a few studies have demonstrated a shuttle-cargo transport mechanism and due to cargo leakage, the selectivity is not comparable to that of the biological system. Other recent approaches are based on DNA origami, though biomolecule transport has not yet been studied with these. The highest selectivity has been achieved with macroscopic gels, but they are yet to be scaled down to nano-dimensions. It is concluded that although several interesting studies exist, we are still far from achieving selective and efficient artificial shuttle-cargo transport of biomolecules. Besides being of fundamental interest, such a system could be potentially useful in bioanalytical devices.

Oxygen plasma-enhanced covalent biomolecule immobilization on SU-8 thin films: A stable and homogenous surface biofunctionalization strategy

SU-8 is an attractive platform for the development of smart biochips owing to its high aspect ratio of micro/nanostructures fabrication and remarkable optical and biocompatible properties. However, few works have explored sub-micron SU-8 thin films for applications in new generations of portable bioanalytical devices. In this work we discuss surface properties for the efficient immobilization of different bioanalytical components on SU-8 thin film surfaces. Short exposure time oxygen plasma treatment improved hydrophilicity and activation of surface carboxyl groups of 300 nm-thick SU-8 films, while maintaining surface roughness below 2 nm. Under these optimized surfaces conditions, covalent immobilization of Interleukin-6 and Prostate Specific Antigen antibodies on SU-8 surfaces was evaluated using quantitative fluorescence microscopy. The addition of standard crosslinker, 1-ethyl-3-(3-(dimethylamino)-propyl)-carbodiimide and N-hydroxysuccinimide mixture to our protocol yielded 15–20% higher antibody immobilization due to activation of surface carboxyl groups. The stability of the plasma treatment along time, and the ideal surface passivation of functionalized samples are demonstrated, along with the selective immobilization antibody to photolithographically-patterned SU-8 microstructures. Overall, our optimized protocol could find broad applications of functionalized SU-8 thin films in biomedical fields, particularly for the fabrication of SU-8 based miniaturized photonic and plasmonic biosensors.

Site-Specific Biofunctionalization of Cellulose and Poly(dimethylsiloxane): A Chemoenzymatic Approach for Surface Engineering.

Site-specific, covalent immobilization of protein is of great importance in the design of bioanalytical devices. User-defined covalent coupling of protein onto the surface has been primarily limited to a noncanonical amino acid or cysteine residues. It is desirable to develop a new approach for site-specific biofunctionalization. Herein, we demonstrate a robust and modular chemoenzymatic approach for site-specific, covalent grafting of proteins onto a surface. The synthetic strategy relies on the combination of surface amine functionalization, followed by sortase-mediated coupling. The developed method was validated by site-specific immobilization of two model proteins (glutathione S-transferase and green fluorescent protein) on cellulose and polydimethylsiloxane surfaces via a short recognition motif (LPETG). The covalent coupling of immobilized proteins at the interface was characterized by Fourier Transform Infrared Spectroscopy in attenuated total reflectance mode, X-ray photoelectron spectroscopy, atomic force microscope, and fluorescent microscopy. This enzymatic surface functionalization approach could permit an oriented, homogeneous, and site-specific covalent tethering of LPETG-tag proteins to other materials under mild conditions.

Biosensors and Bioanalytical Devices based on Magnetic Particles: A Review.

Magnetic particles play an important role in current technology, and this field of technology extends to a broader progression. The term magnetic particles typically cover the paramagnetic particles and super-paramagnetic particles. Various materials like iron oxide are common, but other materials are available as well; a survey of such materials has been included in this work. They can serve for technological purposes like separation and isolation of chemical products or toxic waste, their use in the diagnosis of pathologies, drug delivery and other similar applications. In this review, biosensors, bioanalytical devices and bioassays, have been discussed. Materials for magnetic particles preparation, methods of assay, biosensors and bioassays working in stationary as well as flow-through arrangements are described here. A survey of actual literature has been provided as well.

Recent Developments in Ozone Sensor Technology for Medical Applications.

There is increasing interest in the utilisation of medical gases, such as ozone, for the treatment of herniated disks, peripheral artery diseases, and chronic wounds, and for dentistry. Currently, the in situ measurement of the dissolved ozone concentration during the medical procedures in human bodily liquids and tissues is not possible. Further research is necessary to enable the integration of ozone sensors in medical and bioanalytical devices. In the present review, we report selected recent developments in ozone sensor technology (2016–2020). The sensors are subdivided into ozone gas sensors and dissolved ozone sensors. The focus thereby lies upon amperometric and impedimetric as well as optical measurement methods. The progress made in various areas—such as measurement temperature, measurement range, response time, and recovery time—is presented. As inkjet-printing is a new promising technology for embedding sensors in medical and bioanalytical devices, the present review includes a brief overview of the current approaches of inkjet-printed ozone sensors.

Bioanalytical Device Design With Model-Based Systems Engineering Tools

Development of bioanalytical devices requires a multidisciplinary team working together. In the current article, the model-based systems engineering (MBSE) methodology is applied for the design of a bioanalytical device, in order to create a unique system model with consistency of model elements and relations. This allows a multidisciplinary team to work together in order to define and develop the overall system, from bio/chemical processes to software, hardware, and mechanics; for example, scientists may express bio/chemical events in the system model in a way that the design engineers understand the process and requirements, learn the constraints, and develop the system accordingly. In the article, a tailored version of the object-oriented systems engineering method modeling method was used together with systems modeling language. The major steps of the modeling method utilized include define problem, define context level, define technical requirements, define logical level, and define physical level. The modeling method developed for the article may be used as a base for the development of bioanalytical devices. There is a market push to develop new bioanalytical devices, such as point of care sensors. It is believed that the transformation of the product lifecycle process from document centric to MBSE will provide a competitive advantage to the life sciences industry.

Emerging Applications of Additive Manufacturing in Biosensors and Bioanalytical Devices

AbstractThe progress of additive manufacturing (AM), known as 3D‐printing, has initiated a revolution in the new generation of biosensors and bioanalytical devices in recent years. The advancement in the resolution of AM has enabled the microfabrication of the architectures of electrodes and sensing layers for high‐performance sensing. Diversiform printable materials, including biocompatible materials, polymers, various gels and metals, have enormously broadened the horizon in sensors and analytical devices for both research and commercial purposes. The considerable shortening of time and cost in sensor prototyping and fabrication has been reported and various highly customizable biosensing platforms and devices are under development. Herein, the most recent studies on the applications of AM in biosensors and bioanalytical devices are summarized with the aim to provide a panorama of emerging 3D‐printing strategies for sensor design and bioanalytical device fabrication.

Development of Bio Analytical Devices Based on Nanoimprint Lithography

Development of Bio Analytical Devices Based on Nanoimprint Lithography

Thin hydrogel coatings formation catalyzed by immobilized enzyme horseradish peroxidase

ABSTRACTEnzymes can be a renewable source of catalytic agents and thus be interesting for sustainable approaches to create and modify functional materials. Here, thin hydrogel layers were prepared as thin coatings on hard substrates by immobilized horseradish peroxidase. Hydrophilic 4-arm star shaped telechelics from oligo(ethylene glycol) bearing on average 55% end groups derived from aromatic amino acids served as monomers and enzymatic substrates. Shifts of the contact angle from 84° to 62° for the wetting process and of zeta potential towards the neutral range illustrated an alteration of physicochemical properties of the model surfaces by a hydrophilic shielding. Time-of-flight secondary ion mass spectrometry (ToF-SIMS), quartz crystal microbalance and atomic force microscopy (AFM) experiments enabled the qualitative and quantitative proof of hydrogel deposition at the interface with thicknesses in the medium nanometer size range. Conceptually, as the immobilized enzyme becomes entrapped in the hydrogel and the crosslinking mechanism bases on a radical reaction after enzymatic activation of the monomers with a limited diffusivity and lifetime, the formed network material can be assumed to be inhomogeneous on the molecular level. On the macroscale, however, relative homogeneity of the coating was observed via ToF-SIMS and AFM mapping. As an exemplary functional evaluation in view of bioanalytical applications, the thrombogenicity of the coating was studied in static tests with human blood from several donors. In the future, this “coating-from” approach may be explored for cell culture substrate coatings, for protein/biofilm repellence in technical applications, or in bioanalytical devices.